Free Trial

Galectin Therapeutics (GALT) Earnings Date, Estimates & Call Transcripts

Galectin Therapeutics logo
$1.35 +0.02 (+1.65%)
Closing price 04/23/2025 03:58 PM Eastern
Extended Trading
$1.39 +0.04 (+2.81%)
As of 04/23/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Galectin Therapeutics Earnings Summary

Upcoming
Earnings Date
May. 21Before Market OpensEstimated
Consensus EPS
(Mar. 31)
-$0.16
Actual EPS
(Mar. 31)
-$0.19 Missed By -$0.03

Galectin Therapeutics announced Q4 2024 earnings on March 31, 2025, reporting an EPS of -$0.19, which missed the consensus estimate of -$0.16 by $0.03. With a trailing EPS of -$0.76, Galectin Therapeutics' earnings are expected to decrease next year, from ($0.73) to ($0.92) per share.

Q4 2024 Earnings Resources

GALT Upcoming Earnings

Galectin Therapeutics' Q1 2025 earnings is scheduled for Wednesday, May 21, 2025, with a conference call scheduled on Wednesday, May 14, 2025 at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Galectin Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Galectin Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

GALT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Galectin Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.24-$0.24-$0.24
Q2 20251-$0.19-$0.19-$0.19
Q3 20251-$0.63-$0.63-$0.63
Q4 20251-$0.26-$0.26-$0.26
FY 20254($1.32)($1.32)($1.32)

Galectin Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/21/2025
(Estimated)
--------
3/31/2025Q4 2024-$0.16-$0.19 -$0.03-$0.19--
8/13/2024--$0.16-$0.20 -$0.04-$0.20--
5/15/2024Q1 2024-$0.16-$0.19 -$0.03-$0.19--
3/29/2024Q4 2023--$0.16 -$0.16-$0.16--
11/13/2023Q3 2023-$0.16-$0.24 -$0.08-$0.24--
8/14/2023Q2 2023-$0.21-$0.15+$0.06-$0.15--
5/15/2023Q1 2023-$0.21-$0.19+$0.02-$0.19--

Galectin Therapeutics Earnings - Frequently Asked Questions

Galectin Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 21st, 2025 based off last year's report dates. Learn more on GALT's earnings history.

In the previous quarter, Galectin Therapeutics (NASDAQ:GALT) missed the analysts' consensus estimate of ($0.16) by $0.03 with a reported earnings per share (EPS) of ($0.19). Learn more on analysts' earnings estimate vs. GALT's actual earnings.

Galectin Therapeutics (NASDAQ:GALT) has a recorded net income of -$41.07 million. GALT has generated -$0.76 earnings per share over the last four quarters.

Galectin Therapeutics's earnings are expected to decrease from ($0.73) per share to ($0.92) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:GALT) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners